We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Pfizer, Kaiser End Neurontin Off-Label Suit With Fee Deal

Law360, New York (April 17, 2014, 3:25 PM EDT) -- Pfizer Inc. agreed on Wednesday to settle the remaining claims for attorneys’ fees in Kaiser Foundation Health Plan Inc.’s suit against the drugmaker in multidistrict litigation over the allegedly deceptive marketing...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.